Post the release of the Patanjali’s Corona Virus Medicine, Indian Council of Medical Research and AYUSH Ministry have denied to authorize it and with immediate effect asked Patanjali to stop branding and advertisement of the following drug until fully examined and approved.
Ministry of AYUSH on Tuesday said that they came to know that the Patanjali Ayurved Ltd. claimed to developed the medicine for the treatment of Covid-19 through the news floating in media, in a report Ministry asked for the scientific study and facts and complete details of the medicine which is being developed. In addition to that Ministry has also asked for the license and product approvals from respective State license authority for the ayurvedic medicine
“Patanjali Ayurved Ltd. has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined,” the ministry further said.
Patanjali Ayurved claimed that the two ayurved medicines ‘Coronil and Swasari’ have shown 100% positive results during the clinical trial within 7 days of medication except those on life support system.
In an statement, Ramdev said clinical controlled study of these medicines was done in several cities and the RCT (Randomized Clinical Trial) controlled with placebo was conducted at Jaipur-based National Institute of Medical Sciences & Research.